Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.01853
European Journal of Endocrinology, Vol 152, Issue 3, 437-442
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadjidakis, D J
Right arrow Articles by Raptis, S A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadjidakis, D J
Right arrow Articles by Raptis, S A

CLINICAL STUDY

Diabetes and premature menopause: is their co-existence detrimental to the skeleton?

D J Hadjidakis, A M Mylonakis, M E Sfakianakis, A E Raptis and S A Raptis

2nd Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, Athens University, ‘Attikon’ and ‘Evgenidion’ Hospitals, Athens, Greece

(Correspondence should be addressed to D J Hadjidakis, 2nd Department of Internal Medicine-Propaedeutic and Research Institute, Athens University, PO Box 171 51, Athens 100 24, Greece; Email: dhadjida{at}med.uoa.gr)

Objective: Premature menopause is a known risk factor for osteoporosis, whilst the influence of type 2 diabetes on bone mineral density (BMD) is still controversial.

Design and methods: BMD values assessed by dual-energy X-ray absorptiometry (DXA) in L2–L4 vertebrae and the femoral neck (FN) of 40 diabetic women with premature menopause (D-EMP) were compared with those of 60 non-diabetic, prematurely menopausal women (EMP) and 60 diabetic women with normal menopause (D-NMP) who had been matched by age and body mass index (BMI). In all women, the time elapsed since menopause ranged between 10 and 25 years and the duration of diabetes exceeded 75% of the postmenopausal time period. The age of D-EMP women was 58.7±5 years (mean±1 S.D.), age at menopause 39.5±2.7, years since menopause 18.6±4.9, BMI 27.8±4.3 kg/m2 and duration of diabetes 13.9±3.9 years.

Results: Vertebral BMD values of D-EMP women were significantly higher than those of EMP women (0.908±0.135 vs. 0.817±0.14 g/cm2, P = 0.002), although there was no significant difference between D-EMP and D-NMP women (0.886±0.15 g/cm2). No significant differences were observed in FN BMD values between all groups. Age-adjusted BMD values (Z scores) of D-EMP women were higher than EMP women in both anatomic sites (P < 0.01), but did not differ from D-NMP women. In contrast to the other two groups, no statistically significant correlation was observed in D-EMP women between the BMD values of either anatomic area and the time elapsed since menopause. HbA1c values were positively correlated only to vertebral BMD values of the D-EMP group (P < 0.05). No correlation was observed between the BMD values and the duration of diabetes either in D-EMP or in D-NMP women.

Conclusions: Type 2 diabetes seems to positively affect the mineral density of the trabecular bone in women with premature menopause. The duration of diabetes does not appear to influence bone mass.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 European Society of Endocrinology.